Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masayoshi Takaeda is active.

Publication


Featured researches published by Masayoshi Takaeda.


American Journal of Kidney Diseases | 1994

Risk Factors for Infection and Immunoglobulin Replacement Therapy in Adult Nephrotic Syndrome

Makoto Ogi; Hitoshi Yokoyama; Naohisa Tomosugi; Yukimasa Hisada; Satoshi Ohta; Masayoshi Takaeda; Takashi Wada; Takero Naito; Kenzo Ikeda; Satoshi Goshima; Kazuya Takasawa; Kenichi Kobayashi

Infection has been recognized as an important cause of morbidity and mortality in children with nephrotic syndrome. However, the incidence and severity of infection and the mechanisms responsible for the increased susceptibility to infection are still unclear in adults. We studied 86 consecutive adult patients with nephrotic syndrome but no diabetic nephropathy. Risk factors for infection were evaluated by logistic regression analysis. Infections were found in 16 patients (19%), of whom six died of infection and two developed end-stage renal failure associated with infection. The relative risk for bacterial infection among patients with serum immunoglobulin G (IgG) levels below 600 mg/dL was 6.74 compared with that for patients with serum IgG levels over 600 mg/dL (95% confidence interval, 1.22 to 36.32; P = 0.029). In patients with serum creatinine levels over 2.0 mg/dL, the relative risk of bacterial infection was 5.31 compared with patients with serum creatinine levels below 2.0 mg/dL (95% confidence interval, 1.08 to 26.09; P = 0.040). Intravenous immunoglobulin (10 to 15 g) was administered prospectively every 4 weeks to 18 patients with serum IgG levels below 600 mg/dL until serum IgG levels increased to over 600 mg/dL. Administration of immunoglobulin resulted in a decreased rate of bacterial infections to a level equal to that in patients with endogenous levels over 600 mg/dL. These data indicate that hypogammaglobulinemia and renal insufficiency are independent risk factors for bacterial infection in adult patients with nephrotic syndrome. The effects of intravenous immunoglobulin suggest that maintenance of serum IgG levels over 600 mg/dL may reduce the risk of infection.


Nephron | 1992

Intraglomerular Expression of MHC Class II and Ki-67 Antigens and Serum γ-lnterferon Levels in IgA Nephropathy

Hiioshi Yokoyama; Masayoshi Takaeda; Takashi Wada; Makoto Ogi; Naohisa Tomosugi; Toshikazu Takabatake; Toshio Abe; Mitsuhiro Yoshimura; Hiroshi Kida; Kenichi Kobayashi

In order to clarify intraglomerular cellular activation and cytokine involvement in IgA nephropathy, the glomerular expression of MHC class II antigens (HLA-DR and DQ) and cellular proliferative nucle


Nephron | 1997

Glomerular ICAM-1 Expression Related to Circulating TNF-α in Human Glomerulonephritis

Hitoshi Yokoyama; Masayoshi Takaeda; Takashi Wada; Satoshi Ohta; Yukimasa Hisada; Chikako Segawa; Kengo Furuichi; Kenichi Kobayashi

To clarify the in vivo involvement of cellular adhesion molecules and cytokines in human glomerulonephritis, we have investigated the glomerular and interstitial expression of intercellular adhesion m


American Journal of Nephrology | 2002

High Endothelial Venule-Like Vessels in the Interstitial Lesions of Human Glomerulonephritis

Masayoshi Takaeda; Hitoshi Yokoyama; Chikako Segawa-Takaeda; Takashi Wada; Kenichi Kobayashi

To clarify the characteristics of high endothelial venule (HEV) -like vessels in the interstitium of human glomerulonephritis, we investigated the expression of HEVs related molecules such as P-selectin and L-selectin ligands; MECA-79 epitope and variant sulfated forms of sialyl Lewis X (variant sLeX, clones 2H5, 2F3, GS-13 and GS-36) in kidney specimens by means of immunohistochemical studies, and P-selectin and hevin mRNA signals by using in situ hybridization analyses. In lymphoid organs, HEVs strongly expressed P-selectin, MECA-79, variant sLeX and hevin mRNA signals. In normal kidneys (n = 4), only P-selectin was faintly positive in the vessels of interstitium, but other molecules could not be detected. Interstitial P-selectin expression was upregulated in patients with tubulointerstitial diseases (n = 4) and proliferative glomerulonephritis (n = 51) such as IgA-related nephropathy (n = 39), membranoproliferative glomerulonephritis (n = 4) and crescentic glomerulonephritis (n = 2), but not in nonproliferative glomerular diseases (n = 39) such as minimal change nephrotic syndrome (n = 18) (1.00 ± 0.41, 0.64 ± 0.11, 0.21 ± 0.05, respectively). Interstitial P-selectin expression also correlated with interstitial local cellular infiltration (r = 0.60, p < 0.0001). In addition, P-selectin mRNA signals were detected on the peritubular capillaries and HEV-like vascular endothelial cells. MECA-79 and variant sLeX (2H5 and 2F3) were weakly expressed on the HEV-like vessels located at the corticomedullary regions in three cases (7%) and in nine cases (27%) with interstitial cellular infiltration, respectively. However, we could not detect GS-13, GS-36 or hevin mRNA signals in the diseased kidney specimens. In conclusion, HEV-like vessels in renal interstitium expressed molecules somewhat different from HEVs in lymphoid organs and were associated with interstitial leukocyte accumulation in human proliferative glomerulonephritis possibly through the de novo expression of P-selectin and partly L-selectin ligands (MECA-79 epitope and variant sLeX) in the interstitial lesions.


Kidney International | 1997

In situ expression and soluble form of P-selectin in human glomerulonephritis

Chikako Segawa; Takashi Wada; Masayoshi Takaeda; Kengo Furuichi; Ichirou Matsuda; Yukimasa Hisada; Satoshi Ohta; Kazuya Takasawa; Shin-ichi Takeda; Kenichi Kobayashi; Hitoshi Yokoyama


Kidney International | 1992

Up-regulated MHC-class II expression and γ-IFN and soluble IL-2R in lupus nephritis

Hitoshi Yokoyama; Toshikazu Takabatake; Masayoshi Takaeda; Takashi Wada; Takero Naito; Kenzo Ikeda; Satoshi Goshima; Kazuya Takasawa; Naohisa Tomosugi; Kenichi Kobayashi; Hiroshi Kida


Nephrology Dialysis Transplantation | 1999

The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy

Hitoshi Yokoyama; Satoshi Goshima; Takashi Wada; Masayoshi Takaeda; Kengo Furuichi; Kenichi Kobayashi; Hiroshi Kida


Internal Medicine | 2007

Effect of Sevelamer Hydrochloride on Markers of Bone Turnover in Japanese Dialysis Patients with Low Biointact PTH Levels

Yasunori Iwata; Takashi Wada; Hitoshi Yokoyama; Tadashi Toyama; Shinji Kitajima; Toshiya Okumura; Akinori Hara; Junya Yamahana; Izaya Nakaya; Motoo Kobayashi; Kiyoki Kitagawa; Satoshi Kokubo; Keiichi Yoshimoto; Kazuaki Shimizu; Norihiko Sakai; Kengo Furuichi; Yoshitaka Koshino; Shin-ichi Takeda; Kazuya Takasawa; Satoshi Ohta; Masayoshi Takaeda; Chikako Takaeda; Shuichi Kaneko


Internal Medicine | 2002

Intestinal Obstruction in Autosomal Dominant Polycystic Kidney Disease

Kaheita Kakinoki; Yatsugi Noda; Masayoshi Takaeda; Masahiro Kubo; Keiichi Mizuhashi; Ichirou Miyamoto; Tetsuya Nishida; Yasuhiro Takemori


Nephron | 1997

Subject Index Vol. 76,1997

Toshimitsu Niwa; Y. Vanrenterghem; P. Stratta; C. Canavese; S. Ferrero; A. Grill; G. Piccoli; Natale G. De Santo; Pietro Anastasio; Lucia Spitali; Massimo Cirillo; Domenico Santoro; Rosa Maria Pollastro; Eleonora Cirillo; Dorotea Capodicasa; G. Capasso; José B. Lopes de Faria; Rogério Friedman; Salvatore de Cosmo; Rosemary Dodds; James J. Mortton; Giancarlo Viberti; Alois Sellmayer; Christoph Jeschke; Harald Fricke; Helmut Schiffl; Hitoshi Yokoyama; Masayoshi Takaeda; Takashi Wada; Satoshi Ohta

Collaboration


Dive into the Masayoshi Takaeda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hitoshi Yokoyama

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge